Literature DB >> 23809549

Oseltamivir resistance during treatment of H7N9 infection.

Alan J Hay1, Frederick G Hayden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23809549     DOI： 10.1016/S0140-6736(13)61209-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  25 in total

1.  Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

Authors:  Yanmei Hu; Jiantao Zhang; Rami Ghassan Musharrafieh; Chunlong Ma; Raymond Hau; Jun Wang
Journal:  Antiviral Res       Date:  2017-08-02       Impact factor: 5.970

2.  Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses.

Authors:  Jiantao Zhang; Yanmei Hu; Raymond Hau; Rami Musharrafieh; Chunlong Ma; Xu Zhou; Yin Chen; Jun Wang
Journal:  Eur J Pharm Sci       Date:  2019-03-28       Impact factor: 4.384

3.  Effective strategy for managing H7N9 virus infection.

Authors:  R Song; X Li
Journal:  Infection       Date:  2013-12-10       Impact factor: 3.553

4.  Effective strategy for managing H7N9 virus infection.

Authors:  S Wiwanitkit; V Wiwanitkit
Journal:  Infection       Date:  2014-02       Impact factor: 3.553

5.  Screening of neuraminidase inhibitors from traditional Chinese medicine by transverse diffusion mediated capillary microanalysis.

Authors:  Haiyan Zhao; Zilin Chen
Journal:  Biomicrofluidics       Date:  2014-08-27       Impact factor: 2.800

6.  Electrochemical assay to detect influenza viruses and measure drug susceptibility.

Authors:  Xiaohu Zhang; Abasaheb N Dhawane; Joyce Sweeney; Yun He; Mugdha Vasireddi; Suri S Iyer
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-30       Impact factor: 15.336

7.  Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Juan A De La Cruz; Charles T Davis; Julie M Villanueva; Alicia M Fry; Larisa V Gubareva
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

8.  H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs.

Authors:  Bao Danqi; Zejun Li; Qinfang Liu; Juergen A Richt
Journal:  Expert Rev Anti Infect Ther       Date:  2017-07-17       Impact factor: 5.091

9.  Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity.

Authors:  Anthony DiPiazza; Katherine Richards; Nicholas Poulton; Andrea J Sant
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

10.  Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutants.

Authors:  Weng Ieong Tou; Kun-Lung Chang; Tung-Ti Chang; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  J Mol Model       Date:  2015-12-08       Impact factor: 1.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.